Background and Objectives Individuals exposed to fentanyl are at risk of precipitated
withdrawal using typical buprenorphine/naloxone induction procedures. Methods This case …

Abstract Introduction and Aims North America is currently experiencing an epidemic of
opioid overdose deaths, driven by the proliferation of fentanyl in the street drug market …

Objectives: Buprenorphine can precipitate withdrawal in opioid-dependent persons with
recent fentanyl use. However, the prevalence of this phenomenon is not clinically …

Objectives: There has been a rapid increase in the presence of illicitly manufactured fentanyl
in the heroin drug supply. Buprenorphine is an effective treatment for heroin and prescription …

Background Induction of buprenorphine, an evidence-based treatment for opioid use
disorder (OUD), has been reported to be difficult for people with heavy use of fentanyl, the …

Despite data supporting its efficacy, barriers to implementation of buprenorphine for office-
based treatment are present. Complications can occur during buprenorphine inductions, yet …

Background and Objectives Buprenorphine/naloxone has been shown to be effective in the
treatment of opioid use disorder. Due to its pharmacological properties, induction can be …

With the worst opioid overdose death crisis in the United States history, urgent new
approaches to assist people who use drugs onto medication for opioid use disorder are …

Background The requirement for moderate withdrawal prior to initiation can be a barrier to
buprenorphine/naloxone induction. Case presentation We aimed to use a microdosing …

Abstract Background Conducted in the Dayton Metropolitan area of Southwestern Ohio, this
qualitative study explores the self-treatment practices of people who use illicit opioids …